PillSuspension · Intramuscular
Influenza Virus Vaccine
Brands: Fluarix 2026/2027 · Flulaval 2026/2027 · Influenza A Virus A/Croatia/10136rv/2023 X-425a (H3n2) Antigen (Formaldehyde Inactivated) + Influenza A Virus A/Victoria/4897/2022 Ivr-238 (H1n1) Antigen (Formaldehyde Inactivated) + Influenza B Virus B/Austria/1359417/2021 Bvr-26 Antigen (Formaldehyde Inactivated)
0 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
0 active makers
0 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)2740120
US makers2 labelers
Packages2
DEA / ScheduleNone
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it0 active · 2 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| GlaxoSmithKline Biologicals SA | unknown | 1 | EXITED 2027 |
| ID Biomedical Corporation of Quebec | unknown | 1 | EXITED 2027 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.